# Contrast Ultrasound Perfusion Imaging in PAD With Sonazoid

> **NCT02398266** · PHASE2 · UNKNOWN · sponsor: **Oregon Health and Science University** · enrollment: 55 (estimated)

## Conditions studied

- Peripheral Artery Disease

## Interventions

- **DRUG:** Contrast ultrasound of leg muscle with Sonazoid (Contrast ultrasound microvascular perfusion imaging)

## Key facts

- **NCT ID:** NCT02398266
- **Lead sponsor:** Oregon Health and Science University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-08-01
- **Primary completion:** 2018-07-01
- **Final completion:** 2018-07-01
- **Target enrollment:** 55 (ESTIMATED)
- **Last updated:** 2017-06-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02398266

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02398266, "Contrast Ultrasound Perfusion Imaging in PAD With Sonazoid". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT02398266. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*